• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B. BRAUN AVITUM AG DIALOG+®; KDI-DIALYZER, HIGH PERMEABILIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B. BRAUN AVITUM AG DIALOG+®; KDI-DIALYZER, HIGH PERMEABILIT Back to Search Results
Catalog Number 7102072
Device Problem Calibration Problem (2890)
Patient Problems Hypernatremia (2242); Discomfort (2330)
Event Date 11/01/2022
Event Type  malfunction  
Event Description
As reported by the user facility: patients have been complaining of being extremely thirsty during dialysis treatment and some feel unwell.Patients drinking more fluid than usual because of extreme thirst.Two patients experienced difficulty in breathing hence required them to come for an extra session of dialysis.This report is for event #13.
 
Manufacturer Narrative
This report has been identified as b.Braun medical internal report number (b)(4).Note: this report is being filed for an item number that is not sold in the united states, however similar items are sold in the united states by b.Braun medical inc.We received a report of 11 patients complaining of extreme thirst and/or feeling unwell during dialysis therapy.Two patients experienced difficulty of breathing.These patients came for additional dialysis treatment.No further medical intervention was needed.The dialysis therapies took place on four different machines with serial numbers (b)(4).All of the affected devices were isolated and inspected by a local b.Braun's biomedical technician.Inspection revealed that there was a deviation in the final conductivity of approximately 2 ms/cm in the machines concerned.The consequence of this deviation is that the patients were treated with a higher sodium concentration in the dialysis fluid than intended, thus explaining their thirst.Analysis of the service reports of the affected machines showed that one external contract technician had previously calibrated the temperature and conductivity sensors on these machines.In order to find the root cause of the deviation, the technician's measuring equipment was sent to a testing laboratory for verification.The laboratory's test showed no deviation of the measuring device which could result in a conductivity deviation of approximately 2 ms/cm.For further root cause analysis a technician of the global technical service of b.Braun headquarter, melsungen, germany, was sent to australia to verify all machines in the respective dialysis center.For each machine which was previously serviced by the external contract technician a check and recalibration was performed.The check of the affected machines by the global technical service of b.Braun headquarter confirmed that the external contract manufacturer had set a wrong value when calibrating the conductivity sensors.To avoid a recurrence, the external contract technician was retrained on site by the headquarters' global technical service technician.Generally, each dialysis technician servicing b.Braun machines is certified by training.Calibration of conductivity and temperature sensors is described and explained in detail in the technical service manual and within the technical training course for certification.Since check and recalibration by the headquarters' global technical service technician no further abnormalities occurred.Approximately, 900 treatments are performed per machine per year.This results in 50.400 treatments at an installed base of 56 machines in australia in one year and 151.200 treatments in three years.Approximately, 900 treatments are performed per machine per year.This results in 112.788.900 treatments at an installed base of 125.321 dialog+ machines worldwide in one year and 338.366.700 treatments worldwide in three years.No similar event occurred outside australia in the last three years.Thus, the incident rate of similar events outside australia is 0,0 %.The incident rate worldwide, including australia, is 0,00000384 %.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIALOG+®
Type of Device
KDI-DIALYZER, HIGH PERMEABILIT
Manufacturer (Section D)
B. BRAUN AVITUM AG
schwarzenberger weg 73-79
melsungen, 34212
GM  34212
Manufacturer (Section G)
B. BRAUN AVITUM AG
schwarzenberger weg 73-79
melsungen, 34212
GM   34212
Manufacturer Contact
jonathan severino
901 marcon blvd.
allentown, PA 18109
4847197287
MDR Report Key16723136
MDR Text Key313652298
Report Number3002879653-2023-00004
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number7102072
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/02/2022
Initial Date FDA Received04/12/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-